SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Lifesciences sees temporary slow-down in sales of Ranitidine

11 Oct 2019 Evaluate

SMS Lifesciences India has carried out a preliminary analysis of Ranitidine product and processes and found that the NDMA impurity is in trace levels, in many cases lower than the levels found in commonly consumed food, milk, meat etc. It is awaiting further directives from Central Drugs Standard Control Organization (CDSCO), regulatory agency to review and establish acceptable limits for NDMA (N-Nitrosodimethylamine) impurity in Ranitidine.

As regulatory guidance is awaited for limits of NDMA, the company sees a temporary slow-down in sales of Ranitidine which is one of the major contributor of revenues. The company anticipates business as usual in future as it is confident of providing a safe and stable Ranitidine product to all its customers, with NDMA impurity well within acceptable limits set by the Drug regulator, authorities.

SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, API and Intermediates.

Haleos Labs Share Price

1300.00 1.00 (0.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×